Regulation of alpha-bungarotoxin sites in chromaffin cells in culture by nicotinic receptor ligands, K+, and cAMP

S Geertsen, R Afar, JM Trifaro and M Quik

Department of Pharmacology, McGill University, Montreal, Quebec, Canada.

Previous work had shown that incubation with the nicotinic antagonist d- tubocurarine resulted in a marked increase in alpha-bungarotoxin (alpha- BGT) binding in adrenal medullary chromaffin cells in culture; the possible molecular mechanisms involved in up-regulating the alpha-BGT sites were investigated. To determine whether changes in the extracellular K+ concentration could influence the number of toxin binding sites, the chromaffin cells were incubated in the presence of 2- 50 mM K+; this resulted in an increase in alpha-BGT binding similar to that observed with the nicotinic antagonist. This enhanced binding was maximal with 20 mM K+ and was not due simply to a generalized ion effect, inasmuch as incubation of the cells with a concentration of Na+ of equivalent osmolarity did not alter alpha-BGT binding. Carbachol and the agonist nicotine completely prevented the K+-induced increase in the binding sites. In contrast to the marked up-regulation of the nicotinic alpha-BGT sites by K+, this agent did not increase the acetylcholine-induced release of [3H]noradrenaline from chromaffin cells in culture, further supporting the contention that the nicotinic alpha-BGT site and the functional nicotinic receptor are distinct. The increases in toxin binding due to K+ and d-tubocurarine were partially additive, suggesting that d-tubocurarine and K+ may share a common pathway, but only to a small degree. The calcium channel agonist BAY K 8644 and antagonist D600 had no effect on alpha-BGT binding either alone or in the presence of K+ or d-tubocurarine. On the other hand, forskolin, an activator of adenylate cyclase, and dibutyryl cAMP, an analog of cAMP, partially prevented the K+ and the d-tubocurarine- induced increases in toxin binding. These results suggest an involvement of cAMP in both the nicotinic antagonist-induced and K+- induced up-regulation of the sites. The observation that several mechanisms exist for the fine regulation of the nicotinic alpha-BGT binding sites in adrenal chromaffin cells could imply that this nicotinic receptor population plays a role in this tissue.

Volume 34, Issue 4, pp. 549-556, 10/01/1988
Copyright © 1988 by American Society for Pharmacology and Experimental Therapeutics

This article has been cited by other articles:

				H. R. Santos, H. S. Ribeiro, P. Setti-Perdigao, E. X. Albuquerque, and N. G. Castro The Magnitude of {alpha}7 Nicotinic Receptor Currents in Rat Hippocampal Neurons Is Dependent upon GABAergic Activity and Depolarization J. Pharmacol. Exp. Ther., October 1, 2006; 319(1): 376 - 385. [Abstract] [Full Text] [PDF]

				M. Quik, J. Philie, and J. Choremis Modulation of alpha 7 Nicotinic Receptor-Mediated Calcium Influx by Nicotinic Agonists Mol. Pharmacol., March 1, 1997; 51(3): 499 - 506. [Abstract] [Full Text] [PDF]